Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade

Hepatology

Volumn 51, Issue 6, 2010, Pages 2061-2068

  Pan, Xiaomin ^a   Kelly, Susan ^a   Melin Aldana, Hector ^a   Malladi, Padmini ^a   Whitington, Peter F ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5B; COMPLEMENT MEMBRANE ATTACK COMPLEX;

ARTICLE; CLINICAL ARTICLE; CONGENITAL ALLOIMMUNE HEPATITIS; CONTROLLED STUDY; FETUS; GESTATIONAL AGE; HEMOCHROMATOSIS; HEPATITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LIVER CELL; LIVER CELL DAMAGE; NEONATAL HEMOCHROMATOSIS; NEWBORN DISEASE; PRIORITY JOURNAL;

COMPLEMENT MEMBRANE ATTACK COMPLEX; FETUS; HEMOCHROMATOSIS; HEPATITIS; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; LIVER;

EID: 77952734701     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23581     Document Type: Article

References (32)

1. Knisely AS, Narkewicz MR. Iron storage disorders. In: Suchy FJ, Sokol RJ, Balistreri WF, eds. Liver Disease in Children. 3rd ed. New York, NY: Cambridge University Press; 2007:661-676.
2. Kelly AL, Lunt PW, Rodrigues F, Berry PJ, Flynn DM, McKiernan PJ, et al. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet 2001;38:599-610. (Pubitemid 32835622)
3. Murray KF, Kowdley KV. Neonatal hemochromatosis. Pediatrics 2001;108:960-964.
4. Whitington PF. Fetal and infantile hemochromatosis. HEPATOLOGY 2006;43:654-660.
5. Whitington PF, Fleming RE. Hemochromatosis. In: Kleinman RE, Goulet O-J, Sherman PM, Sanderson IR, Shneider BL, Walker WA, eds. Walker's Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. 5th ed. Hamilton, Canada: BC Decker; 2008:1049-1056.
6. Whitington PF. Neonatal hemochromatosis: a congenital alloimmune hepatitis. Semin Liver Dis 2007;27:243-250.
7. Hoftman AC, Hernandez MI, Lee KW, Stiehm ER. Newborn illnesses caused by transplacental antibodies. Adv Pediatr 2008;55:271-304.
8. Simister NE. Placental transport of immunoglobulin G. Vaccine 2003;21:3365-3369.
9. Clark MR. IgG effector mechanisms. Chem Immunol 1997;65:88-110.
10. Harris RE. Maternal and fetal immunology. Obstet Gynecol 1978;51:733-739.
11. Morgan BP. Mechanisms of tissue damage by the membrane attack complex of complement. Complement Inflamm 1989;6:104-111.
12. Bonilla SF, Melin-Aldana H, Whitington PF. Relationship of proximal renal tubular dysgenesis and fetal liver injury in neonatal hemochromatosis. Pediatr Res 2010;67:188-193.
13. Whitington PF, Malladi P, Melin-Aldana H, Azzam R, Mack CL, Sahai A. Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia. Pediatr Res 2005;57:837-844. (Pubitemid 40727115)
14. Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006;148:652-658. (Pubitemid 43792501)
15. Knisely AS, Mieli-Vergani G, Whitington PF. Neonatal hemochromatosis. Gastroenterol Clin North Am 2003;32:877-889.
16. Silver MM, Valberg LS, Cutz E, Lines LD, Phillips MJ. Hepatic morphology and iron quantitation in perinatal hemochromatosis. Comparison with a large perinatal control population, including cases with chronic liver disease. Am J Pathol 1993;143:1312-1325. (Pubitemid 24057102)
17. Gilmour SM, Hughes-Benzie R, Silver MM, Roberts EA. Le foie vide: a unique case of neonatal liver failure. J Pediatr Gastroenterol Nutr 1996;23:618-623. (Pubitemid 27009115)
18. Stoltzner SE, Grenfell TJ, Mori C, Wisniewski KE, Wisniewski TM, Selkoe DJ, et al. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease. Am J Pathol 2000;156:489-499. (Pubitemid 30643804)
19. Hoogstraten J, de Sa DJ, Knisely AS. Fetal liver disease may precede extrahepatic siderosis in neonatal hemochromatosis. Gastroenterology 1990;98:1699-1701. (Pubitemid 20158641)
20. Witzleben CL, Uri A. Perinatal hemochromatosis: entity or end result? Hum Pathol 1989;20:335-340.
21. Whitington PF, Kelly S, Ekong UD. Neonatal hemochromatosis: fetal liver disease leading to liver failure in the fetus and newborn. Pediatr Transplant 2005;9:640-645. (Pubitemid 41413506)
22. Laurendeau T, Hill JE, Manning GB. Idiopathic neonatal hemochromatosis in siblings. An inborn error of metabolism. Arch Pathol 1961;72:410-423.
23. Fleming RE, Bacon BR. Orchestration of iron homeostasis. N Engl J Med 2005;352:1741-1744.
24. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 2001;98:8780-8785. (Pubitemid 32678104)
25. Knisely AS, Grady RW, Kramer EE, Jones RL. Cytoferrin, maternofetal iron transport, and neonatal hemochromatosis. Am J Clin Pathol 1989;92:755-759.
26. Koch CA, Kanazawa A, Nishitai R, Knudsen BE, Ogata K, Plummer TB, et al. Intrinsic resistance of hepatocytes to complement-mediated injury. J Immunol 2005;174:7302-7309. (Pubitemid 40705700)
27. Morgan BP. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem J 1989;264:1-14.
28. Pilzer D, Gasser O, Moskovich O, Schifferli JA, Fishelson Z. Emission of membrane vesicles: roles in complement resistance, immunity and cancer. Springer Semin Immunopathol 2005;27:375-387. (Pubitemid 41639888)
29. Mack CL. The pathogenesis of biliary atresia: evidence for a virusinduced autoimmune disease. Semin Liver Dis 2007;27:233-242.
30. Rand EB, Karpen SJ, Kelly S, Mack CL, Malatack JJ, Sokol RJ, et al. Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin. J Pediatr 2009;155:566-571.
31. Whitington PF, Hibbard JU. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 2004;364:1690-1698. (Pubitemid 39458145)
32. Whitington PF, Kelly S. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics 2008;121:e1615-e1621.